|
Robert J. Broeze, Ph.D., has over 20 years of experience in the biopharmaceutical industry. His technical expertise spans research, development, characterization, validation, testing and cGMP manufacture of biopharmaceutical products, from pilot to phase III clinical and commercial scale with a strong emphasis on monoclonal antibody products for therapeutic and diagnostic use. Prior to joining Laureate in 1999, Dr. Broeze held positions of Vice President, Biologics Research at Purdue BioPharma L.P. and Vice President, Operations at Bard BioPharma L.P, where he was responsible for the development and manufacture of the company's proprietary monoclonal antibody and biopharmaceutical products.
Prior to this he held positions of increasing responsibility at Cytogen Corporation (Princeton, NJ) with overall responsibility for development and cGMP manufacture of Cytogen's products and at Collaborative Research (Bedford, MA) where he held various technical positions. Dr. Broeze worked as a Postdoctoral Fellow in the Department of Molecular Biophysics & Biochemistry at Yale University where he studied the molecular biology of the interferon system and is a graduate of Rensselaer Polytechnic Institute where he earned both his B.S and Ph.D. degrees. | 